Mettler-Toledo International, Inc. $MTD Shares Bought by CX Institutional

CX Institutional boosted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 18.2% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 175 shares of the medical instruments supplier’s stock after buying an additional 27 shares during the period. CX Institutional’s holdings in Mettler-Toledo International were worth $206,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Greenleaf Trust boosted its stake in Mettler-Toledo International by 1.2% during the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock worth $1,030,000 after buying an additional 10 shares during the last quarter. Brooklyn Investment Group boosted its stake in Mettler-Toledo International by 12.8% during the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock worth $104,000 after buying an additional 10 shares during the last quarter. Albion Financial Group UT boosted its stake in Mettler-Toledo International by 1.5% during the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock worth $890,000 after buying an additional 11 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock worth $740,000 after buying an additional 11 shares during the last quarter. Finally, TD Private Client Wealth LLC boosted its stake in Mettler-Toledo International by 5.4% during the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier’s stock worth $253,000 after buying an additional 11 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 0.6%

MTD stock opened at $1,202.72 on Friday. The company has a market capitalization of $24.78 billion, a PE ratio of 30.46, a P/E/G ratio of 3.61 and a beta of 1.37. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01. The business’s fifty day moving average price is $1,269.22 and its 200 day moving average price is $1,184.76.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.58 by $0.51. The firm had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company’s quarterly revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of the company’s stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares in the company, valued at $368,154.70. This represents a 78.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Gerry Keller sold 165 shares of the company’s stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total value of $215,925.60. Following the sale, the insider owned 94 shares in the company, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock worth $2,371,208 in the last quarter. 1.94% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on MTD. Citigroup upped their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Thursday, August 21st. Robert W. Baird upped their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Evercore ISI decreased their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an “outperform” rating on the stock in a research note on Monday, August 4th. Bank of America upped their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Finally, Barclays began coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an “overweight” rating and a $1,325.00 price target on the stock. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of “Moderate Buy” and a consensus target price of $1,325.56.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.